Appclon has newly appeared among the top searched stocks.

As of 2:33 PM on the 16th, Appclon is trading at 75,700 KRW, up 2.99% from the previous day. This marks a 74.63% increase compared to May 27. Appclon is known as the only domestic bio new drug development specialist among listed companies.

Over the past five days, individual investors have net sold 208,172 shares, while foreigners and institutions have net sold 4,499 shares and net bought 246,376 shares, respectively.

On June 10, Appclon was a market topic with the headline "Effective neutralizing antibodies against all types of COVID-19... Strong expectations for global clinical trials."

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing